News

-
Protagonist Therapeutics Announces Plenary Presentation on VERIFY Phase 3 Study with Rusfertide at ASCO 2025
-
EON Resources Inc. Reports Results for the Fiscal Year 2024 Position the Company for Future Growth
-
Films Using ReelTime's Reel Intelligence (RI) Eligible for Oscars Recognition
-
Pivotree to Release First Quarter 2025 Financial Results
-
MIRA Pharmaceuticals Reports Positive In Vitro Drug Release Data for Topical Ketamir-2, Targeting $11B+ U.S. Topical Pain Relief Market and Exploring FDA Fast Track Designation

-
EQS-Adhoc: STRATEC REPORTS PRELIMINARY BUSINESS RESULTS FOR 2024, PROVIDES GUIDANCE FOR 2025, AND POSTPONES 2024 ANNUAL REPORT
-
H2APEX receives shareholder loan and plans capital increase for further expansion of its hydrogen production capacities
-
EQS-Adhoc: H2APEX Group SCA: Issuance of a Convertible Loan and a Comfort Letter; Planning of a Capital Increase
-
Funding Circle Holdings plc: POS-Transaction in Own Shares
-
Fuller, Smith & Turner PLC: Transaction in own shares

-
Derichebourg annonce son agenda financier pour l’exercice 2024/2025
-
Derichebourg announces its financial calendar for 2024/2025 financial year
-
Entech : Mise à disposition du rapport financier annuel 2024
-
Entech : Rapport Financier Annuel 2024
-
Déclaration des transactions sur actions propres réalisées du 14 au 17 avril 2025